Altered TAOK2 activity causes autism-related neurodevelopmental and cognitive abnormalities through RhoA signaling

Melanie Richter(Universität Hamburg), Nadeem Murtaza(McMaster University), Robin Scharrenberg(Universität Hamburg), Sean H. White(McMaster University), Ole Johanns(Universität Hamburg), Susan Walker(University of Toronto), Ryan K. C. Yuen(University of Toronto), Birgit Schwanke(Universität Hamburg), Bianca Bedürftig(Universität Hamburg), Melad Henis(Universität Hamburg), Sarah Scharf(Universität Hamburg), Vanessa Kraus(Universität Hamburg), Ronja Dörk(Universität Hamburg), Jakob Hellmann(Universität Hamburg), Zsuzsa Lindenmaier(University of Toronto), Jacob Ellegood(Hospital for Sick Children), Henrike Hartung(University of Helsinki), Vickie Kwan(McMaster University), Jan Sedlacik(Universität Hamburg), Jens Fiehler(Universität Hamburg), Michaela Schweizer(Universität Hamburg), Jason P. Lerch(University of Toronto), Ileana L. Hanganu‐Opatz(Universität Hamburg), Fabio Morellini(Universität Hamburg), Stephen W. Scherer(University of Toronto), Karun K. Singh(McMaster University), Froylán Calderón de Anda(Universität Hamburg)
Molecular Psychiatry
February 16, 2018
Cited by 190Open Access
Full Text

Abstract

Atypical brain connectivity is a major contributor to the pathophysiology of neurodevelopmental disorders (NDDs) including autism spectrum disorders (ASDs). TAOK2 is one of several genes in the 16p11.2 microdeletion region, but whether it contributes to NDDs is unknown. We performed behavioral analysis on Taok2 heterozygous (Het) and knockout (KO) mice and found gene dosage-dependent impairments in cognition, anxiety, and social interaction. Taok2 Het and KO mice also have dosage-dependent abnormalities in brain size and neural connectivity in multiple regions, deficits in cortical layering, dendrite and synapse formation, and reduced excitatory neurotransmission. Whole-genome and -exome sequencing of ASD families identified three de novo mutations in TAOK2 and functional analysis in mice and human cells revealed that all the mutations impair protein stability, but they differentially impact kinase activity, dendrite growth, and spine/synapse development. Mechanistically, loss of Taok2 activity causes a reduction in RhoA activation, and pharmacological enhancement of RhoA activity rescues synaptic phenotypes. Together, these data provide evidence that TAOK2 is a neurodevelopmental disorder risk gene and identify RhoA signaling as a mediator of TAOK2-dependent synaptic development.


Related Papers

No related papers found

Powered by citation graph analysis